Can a 39kg girl with dyspnea receive Vistaril (hydroxyzine) in the Emergency Room (ER) for a panic attack?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hydroxyzine Use for Panic Attack with Dyspnea in a 39 kg Child

Hydroxyzine can be safely administered to a 39 kg child experiencing a panic attack with dyspnea in the emergency room setting, with a recommended starting dose of 0.5-1 mg/kg (approximately 20-40 mg). 1

Medication Selection and Dosing

Hydroxyzine is FDA-approved for the symptomatic relief of anxiety and tension associated with psychoneurosis, making it appropriate for panic attacks 1. For pediatric patients:

  • Weight-based dosing: 0.5-1 mg/kg per dose
  • For a 39 kg child: 20-40 mg would be appropriate
  • Route: Oral administration is preferred
  • Onset of action: 15-30 minutes for oral administration

Clinical Assessment Before Administration

Before administering hydroxyzine, assess:

  1. Respiratory status: Ensure dyspnea is due to panic/anxiety rather than a primary respiratory cause
  2. Cardiovascular status: Check heart rate and blood pressure
  3. Current medications: Assess for potential drug interactions
  4. Cardiac history: Hydroxyzine can prolong QT interval 2

Management Algorithm

  1. Rule out organic causes of dyspnea

    • Assess vital signs, oxygen saturation, and respiratory effort
    • Consider physical signs of respiratory distress versus anxiety-induced dyspnea
  2. First-line interventions for panic-induced dyspnea

    • Non-pharmacological approaches: Positioning (sitting upright), cooling the face, opening windows, using small ventilators 3
    • Relaxation techniques and emotional support 3
  3. Pharmacological intervention

    • If non-pharmacological measures are insufficient, proceed with hydroxyzine
    • Start with 0.5 mg/kg (approximately 20 mg for a 39 kg child)
    • Monitor for response and side effects

Special Considerations

  • Sedation: Hydroxyzine may cause sedation, which should be monitored in the emergency setting 4
  • Respiratory monitoring: Although hydroxyzine is generally safe, monitor respiratory status as the patient has presented with dyspnea
  • QT prolongation: Be cautious in patients with known cardiac conditions 2
  • Avoid rapid IV administration: If IV route is necessary (though oral is preferred), administer slowly to prevent potential adverse effects 3

Alternative Approaches

If hydroxyzine is contraindicated or ineffective:

  • For severe anxiety with dyspnea: Consider low-dose benzodiazepines (e.g., lorazepam 0.5-1 mg) 3
  • For persistent dyspnea: If dyspnea persists and is determined to be primarily anxiety-related, consider consultation with pediatric psychiatry for ongoing management

Monitoring After Administration

  • Vital signs every 15-30 minutes
  • Observe for sedation and respiratory status
  • Monitor for resolution of panic symptoms and dyspnea
  • Assess for common side effects: drowsiness, dry mouth, headache

Discharge Considerations

  • Ensure complete resolution of symptoms before discharge
  • Provide education about panic attacks and breathing techniques
  • Consider referral for outpatient mental health follow-up if this is a recurrent issue

Hydroxyzine has demonstrated efficacy for anxiety disorders 4, 5 and is generally well-tolerated in the pediatric population when appropriately dosed. Its antihistamine properties make it a reasonable choice for managing anxiety-induced dyspnea in a child without the risks associated with benzodiazepines.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hydroxyzine for generalised anxiety disorder.

The Cochrane database of systematic reviews, 2010

Research

Recent clinical trials of hydroxyzine in generalized anxiety disorder.

Acta psychiatrica Scandinavica. Supplementum, 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.